Two-step radiolabeling human telomerase reverse transcriptase antisense oligonucleotide with 99mTc and in vivo experiment

Gaohong Zhu,Bingxiu Ren,Yulin Su,Jiangliang Wei,Jing Cai,Lilin Chen,Bin Song
2013-01-01
Abstract:Objective: To offer a basic technique for detecting human telomerase reverse transcriptase antisense oligonucleotide (hTERT ASON) in vivo with nuclear medicine modality. Materials: Firstly, 1, 4, 7, 10-tetraazacyclododecane-N, N', N″, N‴-tetraacetic acid (DOTA), 1-(3-dimethylaminoptoply)-3-ethylcarbodimide hydrochloride (EDO and N-hydroxy-sulfosuccinimide sodium (S-NHS) were mixed in pH 5.5 phosphate buffered solution (PBS) with a molecular ratio of 10:5:4, and stirred for 30 min at room temperature (RT). Then the activated DOTA and hTERT ASON were mixed (with a molecular ratio of 75:1) in pH 7.0 PBS and stirred for 4 h at RT. The mixed solution was purified through dialysis tube in pH 7.0 PBS for 8 h. Secondly, 0.3 ml (33 μg) of DOTA-ASON and 10 μl of prepared MDP kit (5 mg/ml) were mixed, and then 370 MBq of 99mTc-pertechnetate elute (0.2 ml) was dropped into the mixed solution and stirred for 45 min at 37°C, thin layer chromatography (TLC) and G25-gel chromatography were applied to detect the labeling rate and radiochemical purity (RCP). Finally, in vitro stability and cellular test were performed, and immunohistochemical staining was used to measure the telomerase activity of HepG2 cells after incubating with antisense probes. Results: The labeling rate of 99mTc-DOTA-ASON reached (79.62 ± 4.44)% with a high RCP of (96.22 ± 2.43)%. The radiolabeled antisense probes showed perfect stability at 37°C in fresh human serum over 24 h with RCP (higher than 90%) and degraded ASON (lower than 15%). Compared with human umbilical vein endothelial cell (HUVEC), HepG2 cells showed obviously higher uptake of 99mTc-DOTA-ASON ([8.32 ± 0.34]% vs. [5.10 ± 0.41]%, P<0.001). Conclusion: The high radio labeling rate and RCP of 99mTc-DOTA-ASON and its good stability in vitro and in serum present that 99mTc-DOTA-ASON can be used as a potential probe for nuclear imaging targeting telomerase iv vivo. Copyright © 2013 by the Press of Chinese Journal of Medical Imaging Technology.
What problem does this paper attempt to address?